
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Comorbidities in patients with polymyalgia rheumatica prior to and following diagnosis: A case control and cohort study”, Semin Arthritis Rheum, vol. 50, pp. 663-672, 2020.
, “Development and validation of the DIabetes Severity SCOre (DISSCO) in 139 626 individuals with type 2 diabetes: a retrospective cohort study”, BMJ Open Diabetes Res Care, vol. 8, 2020.
, “Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs”, Rheumatology (Oxford), 2020.
, “Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction”, Heart, 2020.
, “Mortality among patients with polymyalgia rheumatica: A retrospective cohort study”, Arthritis Care Res (Hoboken), 2020.
, “Rheumatological conditions as risk factors for self-harm: A retrospective cohort study”, Arthritis Care Res (Hoboken), 2020.
, ,
,
“Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study”, Ann Rheum Dis, vol. 77, pp. 1750-1756, 2018.
, “Predictors and temporal trend of flu vaccination in auto-immune rheumatic diseases in the UK: a nationwide prospective cohort study”, Rheumatology (Oxford), vol. 57, pp. 1726-1734, 2018.
, “Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study”, Arthritis Res Ther, vol. 20, p. 243, 2018.
, “Risk of fragility fracture among patients with gout and the effect of urate-lowering therapy”, Cmaj, vol. 190, pp. E581-e587, 2018.
, “Factors Influencing Allopurinol Initiation in Primary Care”, Ann Fam Med, vol. 15, pp. 557-560, 2017.
, “Incident acute pseudogout and prior bisphosphonate use: Matched case-control study in the UK-Clinical Practice Research Datalink”, Medicine (Baltimore), vol. 96, p. e6177, 2017.
, “Rheumatoid arthritis is getting less frequent-results of a nationwide population-based cohort study”, Rheumatology (Oxford), vol. 56, pp. 736-744, 2017.
, “An algorithm to identify rheumatoid arthritis in primary care: a Clinical Practice Research Datalink study”, BMJ Open, vol. 5, p. e009309, 2015.
, “Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink”, Ann Rheum Dis, vol. 74, pp. 642-7, 2015.
, “Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database”, Ann Rheum Dis, vol. 73, pp. 1769-73, 2014.
, “Risk of vascular events in patients with polymyalgia rheumatica”, Cmaj, vol. 186, pp. E495-501, 2014.
,